Form 4: GoodRx CFO Karsten Voermann Reports Stock Transactions
SEC Form 4 Filing
Karsten Voermann, CFO of GoodRx Holdings, Inc., reported the vesting and subsequent disposal of shares related to restricted stock units on March 8, 2024.
Summary
- On March 8, 2024, Karsten Voermann, the Chief Financial Officer of GoodRx Holdings, Inc., reported transactions involving Class A Common Stock.
- Voermann vested 54,064 shares of Class A Common Stock from restricted stock units.
- Simultaneously, Voermann disposed of 17,240 shares to cover tax obligations at a price of $7.54 per share.
- Following these transactions, Voermann directly owns 211,952 shares of Class A Common Stock and 540,640 restricted stock units.
Sentiment
Score: 5
Explanation: This is a neutral report of stock transactions by an executive, with no inherent positive or negative implications for the company's performance.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider and doesn't necessarily reflect broader industry trends.
Stakeholder Impact
- The transactions have a minimal impact on shareholders as they represent routine activity related to executive compensation.
Key Dates
| Date | Description |
|---|---|
| 12/08/2022 | Initial vesting date for the restricted stock unit award, with 6.25% of the underlying shares vesting. |
| 03/08/2024 | Date of the reported transactions: vesting of restricted stock units and disposal of shares for tax obligations. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.